Trials / Completed
CompletedNCT00627302
Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bp Consulting, Inc · Network
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-400 | Day of Surgery: Starting 2 hours after surgery Instill one drop in randomized eye every two hours. Day 1-Week 1: Instill one drop in randomized eye four times daily |
| DRUG | Systane | Day of Surgery: Starting 2 hours after surgery Instill one drop in randomized eye every two hours. Day 1-Week 1: Instill one drop in randomized eye four times daily |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2008-03-03
- Last updated
- 2008-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00627302. Inclusion in this directory is not an endorsement.